US Stock MarketDetailed Quotes

ATXS Astria Therapeutics Inc

Watchlist
  • 9.360
  • -0.190-1.99%
Close Dec 18 16:00 ET
  • 9.990
  • +0.630+6.73%
Pre 04:36 ET
528.22MMarket Cap-4.29P/E (TTM)

About Astria Therapeutics Inc Company

Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway. The company was founded by Michael R. Jirousek, Jill C. Milne and Steven E. Shoelson on June 26, 2008 and is headquartered in Boston, MA.

Company Profile

SymbolATXS
Company NameAstria Therapeutics Inc
Listing DateJun 25, 2015
Issue Price12.00
Founded2008
CEODr. Jill C. Milne, PhD
MarketNASDAQ
Employees59
Fiscal Year Ends12-31
Address22 Boston Wharf Road,10th floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-617-349-1971
Websitehttp://www.astriatx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jill C. Milne, PhD
  • Director, President and Chief Executive Officer
  • 2.96M
  • Benjamin Harshbarger
  • Chief Legal Officer
  • --
  • Dr. Christopher Morabito, M.D.
  • Chief Medical Officer
  • 1.32M
  • Andrea Matthews
  • Chief Business Officer
  • --
  • Noah Clauser
  • Chief Financial Officer, Principal Accounting Officer and Treasurer
  • 1.35M
  • Andrew Komjathy
  • Chief Commercial Officer
  • --
  • Kenneth M. Bate
  • Chairman of the Board
  • 194.17K
  • Dr. Sunil Agarwal, M.D.
  • Director
  • --
  • Hugh M. Cole
  • Independent Director
  • 151.17K
  • Gregg Anthony Lapointe, C.P.A.,M.B.A.
  • Independent Director
  • 163.67K
  • Frederick C. Callori
  • Independent Director
  • 152.67K
  • Dr. Jonathan Violin, M.B.A.,PhD
  • Independent Director
  • 158.67K
  • Dr. Joanne T. Beck, PhD
  • Independent Director
  • 256.17K
  • Michael D. Kishbauch
  • Independent Director
  • 157.67K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Symbol Mini Chart % Chg
NVIDIA
NVDA
-1.14%
Apple
AAPL
-2.14%
Oracle
ORCL
-2.53%
Adobe
ADBE
-3.06%
Ecopetrol
EC
-3.17%

Unlock the Full List